Abstract
The in vitro activity of tosufloxacin against anaerobic cocci,Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, Bacteroides spp. and fusobacteria was determined by the agar dilution method. This activity was compared with that of ciprofloxacin, piperacillin, cefoxitin, imipenem, clindamycin, metronidazole and chloramphenicol. Tosufloxacin, imipenem, clindamycin, metronidazole and chloramphenicol were the most active agents tested. Tosufloxacin has an antibacterial activity that warrants investigation in clinical trials.
Similar content being viewed by others
References
Fernandes PB, Chu DTW, Swanson RN, Ramer NR, Hanson CW, Bower RR, Stamm JM, Hardy DJ: A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1988, 32: 27–32.
Holdeman LV, Cato EP, Moore WEC: Anaerobe laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg, VA, 1977, p. 1–156.
Dornbusch K, Nord CE, Olsson-Liljequist B: Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scandinavian Journal of Infectious Diseases 1979, 19: 17–25.
National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria. 2nd ed. Document M11-A2. NCCLS, Villanova, PA, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nord, C.E., Lindmark, A., Persson, I. et al. Susceptibility of anaerobic bacteria to tosufloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 11, 263–265 (1992). https://doi.org/10.1007/BF02098095
Issue Date:
DOI: https://doi.org/10.1007/BF02098095